Patent · US Active

Monoclonal antibodies for treatment of cancer

US8354104B2 · kind B2 · utility

3Cited by

34References

5Claims

0Family size

Assignees

Ganymed Pharmaceuticals GmbH · DE
Johannes Gutenberg-Universität Mainz · DE

Inventors

Ugur Sahin · Mainz, DE
Michael Koslowski · Mainz, DE
Ozlem Tureci · Homburg, DE

Key dates

Filing date	Mar 14, 2008
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Oct 1, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing GT468, including tumor-related diseases such as breast cancer, lung cancer, gastric cancer, ovarian cancer, and hepatocellular cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.